Marlene Gyldmark

Direttore/Membro del Consiglio presso International Society for Pharmacoeconomics & Outcomes Rsch

Consumer Services

Commercial Services

Profilo

Marlene Gyldmark is currently the Director at the International Society for Pharmacoeconomics & Outcomes Research.
She has a graduate degree from York University and another graduate degree from the University of Copenhagen.

Posizioni attive di Marlene Gyldmark

Società	Posizione	Inizio
International Society for Pharmacoeconomics & Outcomes Rsch International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Marlene Gyldmark

Formazione di Marlene Gyldmark

University of Copenhagen	Graduate Degree
York University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Marlene Gyldmark

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
International Society for Pharmacoeconomics & Outcomes Rsch International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries.	Commercial Services